GHOSH, D. Metabolic derangements among the Schizophrenia patients consuming second generation atypical antipsychotics-Olanzapine and Aripiprazole: a randomised controlled trial. International Journal of Pharmaceutical and Biological Science Archive, v. 2, n. 6, 28 ago. 2016.